InvestorsHub Logo
Followers 18
Posts 1562
Boards Moderated 0
Alias Born 08/23/2017

Re: None

Tuesday, 12/12/2017 11:18:17 AM

Tuesday, December 12, 2017 11:18:17 AM

Post# of 70442
He wont discuss projections until new year but said it was "favorable".

They intend to make application for uplisting next year. He wont give specific date or even month. I am sure that is for disclosure reasons.

I asked about a R/S again and he said its hot happening. he wont discuss contracts being worked on or possible mergers or acquisitions. Hey it was worth a shot to ask right?

I asked about the company diluting equity and he said they have not nor do they intend to dilute. Debts have been settled due to time of year and audits but he does not consider that dilution because they were owed. As for AS being increased, he said it was necessary for the company to be in alignment with other typical cap structures. I told him that that seems to indicate a merger or acquisition is on the horizon and he told me again he wont discuss that.

I asked if biotech was the only thing on the immediate horizon and he said no. They are apparently working on many things some of which are "sensitive" projects as he put it. I asked what other division will be launched next year and he said all divisions are operational to varying extents but only two others are ready to launch products immediately. Security and Aerospace have been ready but it would require hiring more people which he does not think would be prudent to do at this time so he is waiting. All other divisions can be fully operational with final products within 90-120 days and they all have a pipeline of products designed most with final versions of products completed. The only thing the other divisions need would be a confirmed supply chain, manufacturing schedule and in most cases tooling for specific parts of products. Apparently the company has invested over $7M in R&D